Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.120 GeneticVariation phenotype BEFREE These findings highlight the complexities of aberrant MECP2 function in Rett syndrome and explain some of the variation in manifestation of sleep disturbances. 27255190 2016
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.120 AlteredExpression phenotype BEFREE Alpha-synuclein overexpression in mice produces sleep disruptions and altered oscillatory EEG activity reminiscent of PD, and this model provides a novel platform to assess mechanisms and therapeutic strategies for sleep dysfunction in PD. 24867919 2014
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.120 GeneticVariation phenotype BEFREE Seizures and sleep disturbances were more common than in those with MECP2 mutations whereas features of regression and spinal curvature were less common. 22872100 2013
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.120 GeneticVariation phenotype BEFREE Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice. 23938351 2013
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.120 Biomarker phenotype HPO
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.120 Biomarker phenotype HPO
Entrez Id: 6513
Gene Symbol: SLC2A1
SLC2A1
0.110 Biomarker phenotype BEFREE The shortened period of NREM sleep and prolonged duration of the wake period may resemble the sleep disturbances commonly observed in patients with GLUT1DS and other epilepsy disorders. 31399478 2019
Entrez Id: 23314
Gene Symbol: SATB2
SATB2
0.110 GeneticVariation phenotype BEFREE To determine the nature and frequency of behavioral phenotypes and sleep disturbances in individuals with SATB2-associated syndrome (SAS). 31420882 2019
Entrez Id: 25814
Gene Symbol: ATXN10
ATXN10
0.110 Biomarker phenotype BEFREE Therefore, the aim of this study was to assess sleep disturbances in patients with SCA10. 29624773 2018
Entrez Id: 80816
Gene Symbol: ASXL3
ASXL3
0.110 GeneticVariation phenotype BEFREE We describe a patient with severe developmental delay, feeding problems, short stature, autism, and sleep disturbance with a heterozygous de novo splicing mutation in the ASXL3 gene. 27075689 2016
Entrez Id: 80816
Gene Symbol: ASXL3
ASXL3
0.110 CausalMutation phenotype CLINVAR Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome. 27075689 2016
Entrez Id: 10743
Gene Symbol: RAI1
RAI1
0.110 GeneticVariation phenotype BEFREE Individuals with autism spectrum disorders (ASD) who have an identifiable single-gene neurodevelopmental disorder (NDD), such as fragile X syndrome (FXS, FMR1), Smith-Magenis syndrome (SMS, RAI1), or 2q23.1 deletion syndrome (del 2q23.1, MBD5) share phenotypic features, including a high prevalence of sleep disturbance. 25271084 2015
Entrez Id: 55777
Gene Symbol: MBD5
MBD5
0.110 Biomarker phenotype BEFREE MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes. 25271084 2015
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.110 GeneticVariation phenotype BEFREE Neuropsychiatric, dysautonomic and sleep disturbances occur as frequently in patients with LRRK2-G2019S-PD as in IPD but smell loss was less frequent in LRRK2-PD. 25330404 2014
Entrez Id: 6792
Gene Symbol: CDKL5
CDKL5
0.110 GeneticVariation phenotype BEFREE In four genetically confirmed female patients with CDKL5 mutations (age range 2-15 y), the presence of breathing and sleep abnormalities was evaluated using the validated Sleep Disturbance Scale for Children and polysomnography (PSG). 23151060 2013
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.110 GeneticVariation phenotype BEFREE Neither depression prevalence nor use of antidepressants differed between genetic subtypes, with only sleep disturbance more common in SCA3. 21437988 2011
Entrez Id: 5621
Gene Symbol: PRNP
PRNP
0.110 GeneticVariation phenotype BEFREE A missense mutation in codon 200 (E200K) of the PRNP was identified in this patient; CSF 14-3-3 protein was positive; sleep disturbance was the initial sign and the other symptoms gradually appeared, including memory loss, dizziness and ataxia. 20514992 2010
Entrez Id: 2775
Gene Symbol: GNAO1
GNAO1
0.110 GeneticVariation phenotype BEFREE The cataplectic narcolepsy differed from non-cataplectic narcolepsy by having more rapid eye movement (REM)-related clinical symptoms (more sleep paralysis and sleep-related hallucination) and sleep disturbances (shorter REM latency), as well as tighter association with HLA DQB1*0602. 18388176 2008
Entrez Id: 2775
Gene Symbol: GNAO1
GNAO1
0.110 Biomarker phenotype HPO
Entrez Id: 6513
Gene Symbol: SLC2A1
SLC2A1
0.110 Biomarker phenotype HPO
Entrez Id: 10743
Gene Symbol: RAI1
RAI1
0.110 Biomarker phenotype HPO
Entrez Id: 55777
Gene Symbol: MBD5
MBD5
0.110 Biomarker phenotype HPO
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.110 Biomarker phenotype HPO
Entrez Id: 25814
Gene Symbol: ATXN10
ATXN10
0.110 Biomarker phenotype HPO
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.110 Biomarker phenotype HPO